Vor Biopharma Inc.

VOR·NasdaqGS·Healthcare
Compare
20.12+0.26 (+1.31%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD
Pre-market20.00−0.12 (−0.60%)

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close19.86
Open20.63
Day range19.4920.70
52-week range6.5026.00
Off day high−2.80%
Off 52-week high−22.62%
Volume415.42K
Avg. volume (3M)947.85K
Market cap1.24B
EPS (TTM)300.56
Forward P/E-5.69
P/E ratio (TTM)0.07
Dividend yield—
Beta (5Y)1.83
Shares outstanding61.43M
Short interest14.17% of float
Earnings dateOct 30, 2026
Analyst target39.00
Profit margin0.00%

Against its peers

Compare in full ›
VOR VIR BHVN VERA NKTR LKFT
Market cap 1.24B 1.99B 2.30B 2.30B 1.31B 2.25B
P/E (TTM) 0.1 — — — — 3.2
Forward P/E -5.7 -4.8 -8.2 -7.5 -3.7 -28.6
Price/book -9.0 2.1 -23.4 5.6 1.5 12.2
Dividend yield — — — — — —
1-year change −5.02% +129.88% +78.66% +27.43% −30.19% +9.26%
Today +1.31% +4.90% −2.37% +4.10% +1.91% +6.03%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to Vor Biopharma's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
Vir Biotechnology, Inc.VIR · Biotechnology 1.99B 11.77 +4.90%
Biohaven Ltd.BHVN · Biotechnology 2.30B 15.24 −2.37%
Vera Therapeutics, Inc.VERA · Biotechnology 2.30B 31.97 +4.10%
Nektar TherapeuticsNKTR · Biotechnology 1.31B 38.48 +1.91%
Lakefront Biotherapeutics NVLKFT · Biotechnology 2.25B 34.09 +6.03%
Septerna, Inc.SEPN · Biotechnology 2.23B 47.88 +9.57%
Phathom Pharmaceuticals, Inc.PHAT · Biotechnology 461.74M 5.68 −1.05%
Viva Biotech Holdings1873.HK · Biotechnology 2.80B 1.355 +5.04%

Other companies in Biotechnology, closest in size first.

Company Mkt cap Price Today
Idorsia LtdIDIA.SW · Allschwil, Switzerland 1.17B 4.3300 −1.81%
SpyGlass Pharma, Inc.SGP · Irvine, CA 1.15B 34.45 0.00%
Pharma Mar, S.A.PHM.VI · Madrid, Spain 1.16B 67.05 +0.22%
Verastem, Inc.VSTM · Needham, MA 1.20B 9.85 +0.82%
Avalyn Pharma Inc.AVLN · Boston, MA 1.22B 27.47 +2.46%
Inhibrx Biosciences, Inc.INBX · La Jolla, CA 1.28B 86.76 +7.01%
MannKind CorporationMNKD · Danbury, CT 1.26B 3.9300 +5.36%
Abnova (Taiwan) Corporation4133.TW · Taipei, Taiwan 1.20B 19.85 0.00%

Also based in Boston, Massachusetts, then elsewhere in Massachusetts.

Company Mkt cap Price Today
Vertex Pharmaceuticals IncorporatedVRTX · Boston, MA 139.16B 549.04 +3.44%
American Tower CorporationAMT · Boston, MA 90.37B 194.86 +4.04%
Wayfair Inc.W · Boston, MA 16.92B 123.56 +11.00%
State Street CorporationSTT · Boston, MA 47.18B 173.41 +2.18%
PTC Inc.PTC · Boston, MA 21.20B 195.18 +0.58%
Toast, Inc.TOST · Boston, MAOdds 20.44B 35.37 +5.49%
Dynatrace, Inc.DT · Boston, MA 13.42B 46.78 −0.53%
BXP, Inc.BXP · Boston, MA 11.93B 65.96 +5.32%

The stocks whose daily moves over the past year went most closely with Vor Biopharma's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
Sana Biotechnology, Inc.SANA · Correlation 0.32 766.36M 2.5600 +4.92%
Vir Biotechnology, Inc.VIR · Correlation 0.31 1.99B 11.77 +4.90%
Cullinan Therapeutics, Inc.CGEM · Correlation 0.31 767.61M 12.49 −20.70%
Avalyn Pharma Inc.AVLN · Correlation 0.31 1.22B 27.47 +2.46%

What visitors to Vor Biopharma's page also look at.

Company Mkt cap Price Today
Immunocore Holdings plcIMCR 1.51B 29.23 −2.66%
Cullinan Therapeutics, Inc.CGEM 767.61M 12.49 −20.70%
Design Therapeutics, Inc.DSGN 665.24M 10.63 +2.80%
BioAtla, Inc.BCAB 3.34M 2.0000 +6.95%
Sana Biotechnology, Inc.SANA 766.36M 2.5600 +4.92%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All VOR news ›
Seeking Alpha·Negative

Vor Biopharma reports Q3 results

Vor Biopharma press release (VOR): Q3 Cash, cash equivalents and marketable securities were $481.6 million as of September 30, 2026, which are projected to fund - Cash, cash equivalents, and marketable securities were $481.6 million as of…

VNDAVIR
markets.businessinsider.com·

Wells Fargo Keeps Their Buy Rating on Vor Biopharma (VOR)

Wells Fargo analyst Derek Archila maintained a Buy rating on Vor Biopharma on October 16 and set a price target of $30.00. The company’s shares closed last Friday at $18.03. Archila covers the Healthcare sector, focusing on stocks such as…

VYGRWFC
markets.businessinsider.com·Positive

Citi Sticks to Its Buy Rating for Vor Biopharma (VOR)

In a report released today, Geoff Meacham from Citi maintained a Buy rating on Vor Biopharma, with a price target of $50.00. According to TipRanks, Meacham is a 5-star analyst with an average return of 12.7% and a 56.16% success rate.…

VYGR

From the 4Search news index, newest first.

In the news

4mentions in 30 days
4with it in the headline
Negativesentiment

Mentioned with

Weiss Ratings3Acrivon Therapeutics2Wall Street Zen2Wells Fargo2Adarx Pharmaceuticals1Airbus1Alnylam Pharma1Arrowhead Pharmaceuticals1

People in the coverage

Danessa Lincoln3Derek Archila3Acrivon2Ali Behbahani2Benzinga2H.c. Wainwright2

Themes

Healthcare4Equities2Finanzen2Reiterated Rating2Vygr2Wall Street Zen2Analysis1Biotechnology1

Most coverage from

  1. markets.businessinsider.com2
  2. seekingalpha.com1
  3. themarketsdaily.com1

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 4 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance